Kintor Pharmaceutical Limited develops and markets drugs. The Company produces and sells androgen receptor antagonists, small molecule innovative drugs, and other products. Kintor Pharmaceutical markets its products primarily throughout China with limited overseas.

Next Day Disclosure Return

Announcements and Notices - [Issue of Shares under a General Mandate]

Completion Of Subscription Of New Shares Under
General Mandate

Subscription Of New Shares Under General Mandate

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interim Report 2025

Announcements and Notices - [Other - Business Update]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kintor Pharmaceutical (9939 HK)

Next Day Disclosure Return

Completion Of Subscription Of New Shares Under General Mandate

Subscription Of New Shares Under General Mandate

Interim Report 2025

Voluntary Announcement - Completion Of Enrollment Of Subjects In Long-Term Human Safety Trial Of Kt-939

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)